These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29306856)

  • 1. Mycophenolate mofetil treatment in a patient with recurrent lymphocytic hypophysitis.
    Sawachika H; Kodama S; Mukai T; Morita Y
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29306856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infundibuloneurohypophysitis Associated With Sjögren Syndrome Successfully Treated With Mycophenolate Mofetil: A Case Report.
    Louvet C; Maqdasy S; Tekath M; Grobost V; Rieu V; Ruivard M; Le Guenno G
    Medicine (Baltimore); 2016 Mar; 95(13):e3132. PubMed ID: 27043673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A; Hari P; Moudgil A; Jordan SC
    Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
    Basu B; Babu BG; Mahapatra TK
    Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort study.
    Akatani R; Chihara N; Koto S; Mori S; Kurimoto T; Nakamura M; Tachibana H; Otsuka Y; Ueda T; Omori T; Sekiguchi K; Matsumoto R
    Immunol Med; 2024 Jun; 47(2):85-92. PubMed ID: 38235761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil.
    Lin M; Tsang V; Brewer J; Clifton-Bligh R; Gild ML
    Endocrinol Diabetes Metab Case Rep; 2020 Jul; 2020():. PubMed ID: 32729848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose corticosteroid and mycophenolate for primary treatment of minimal change disease.
    Ma MKM; Yap DYH; Li CL; Mok MMY; Chan GCW; Kwan LPY; Lai KN; Tang SCW
    QJM; 2020 Jun; 113(6):399-403. PubMed ID: 31769845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
    Greiner K; Varikkara M; Santiago C; Forrester JV
    Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris].
    Chams-Davatchi C; Nonahal Azar R; Daneshpazooh M; Valikhani M; Hallaji Z; Barzegari M; Firouz AR; Zakeri M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):23-5. PubMed ID: 11937925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil and deflazacort combination in neuropsychiatric lupus: a decade of experience from a tertiary care teaching hospital in southern India.
    Gupta N; Ganpati A; Mandal S; Mathew J; Goel R; Mathew AJ; Nair A; Ramasamy P; Danda D
    Clin Rheumatol; 2017 Oct; 36(10):2273-2279. PubMed ID: 28785855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent autoimmune hypophysitis treated with rituximab: a case report.
    Kruse M; Olesen TB; Markovic L; Glintborg D; Andersen MS
    J Med Case Rep; 2021 Dec; 15(1):591. PubMed ID: 34906226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisolone-responsive Postpartum IgG4-related Hypophysitis.
    Koide H; Shiga A; Komai E; Yamato A; Fujimoto M; Tamura A; Kono T; Nakayama A; Takiguchi T; Higuchi S; Sakuma I; Nagano H; Hashimoto N; Suzuki S; Takeda Y; Shibuya M; Nishioka H; Yamada S; Inoshita N; Ishiwatari N; Horiguchi K; Yokote K; Tanaka T
    Intern Med; 2018 Feb; 57(3):367-375. PubMed ID: 29093382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.
    Giannakopoulos G; Verbaan H; Friis-Liby IL; Sangfelt P; Nyhlin N; Almer S;
    Dig Liver Dis; 2019 Feb; 51(2):253-257. PubMed ID: 30389427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can mycophenolate mofetil be tapered safely in myasthenia gravis? A retrospective, multicenter analysis.
    Hobson-Webb LD; Hehir M; Crum B; Visser A; Sanders D; Burns TM
    Muscle Nerve; 2015 Aug; 52(2):211-5. PubMed ID: 25906756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.
    Zachou K; Gatselis NK; Arvaniti P; Gabeta S; Rigopoulou EI; Koukoulis GK; Dalekos GN
    Aliment Pharmacol Ther; 2016 May; 43(10):1035-47. PubMed ID: 26991238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].
    Zierhut M; Stübiger N; Aboalchamat W; Landenberger H; Bialasiewicz AA; Engelmann K
    Ophthalmologe; 2001 Jul; 98(7):647-51. PubMed ID: 11490743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis.
    Jesus D; Rodrigues M; da Silva JAP; Inês L
    Lupus; 2018 Jul; 27(8):1358-1362. PubMed ID: 29448882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Triple Combination Immunosuppressive Therapy with Prednisolone, Cyclosporine, and Mycophenolate Mofetil to Treat Recurrent Giant Cell Myocarditis.
    Akita T; Mori S; Onishi A; Hara S; Yamada H; Nagasawa A; Imada H; Shimoura H; Ooka J; Tanaka H; Hirata KI
    Intern Med; 2019 Jul; 58(14):2035-2039. PubMed ID: 30918193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mycophenolate mofetil for induction of remission in Wegener's granulomatosis].
    Kötter I
    Z Rheumatol; 2007 Sep; 66(5):441-3. PubMed ID: 17717676
    [No Abstract]   [Full Text] [Related]  

  • 20. [Case report of introducing MMF and steroids as an immunosuppressive therapy after living-donor liver transplantation for a patient with the diabetic nephropathy].
    Kuramitsu S; Iguchi T; Ninomiya M; Yamashita Y; Harimoto N; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Shirabe K; Kawanaka H; Ikeda T; Furuta T; Tamada R; Maehara Y
    Fukuoka Igaku Zasshi; 2014 Mar; 105(3):79-83. PubMed ID: 25000660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.